Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57(2):285–94.
Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes. 2011;2(11):196–203.
Murphy HR, Bell R, Cartwright C, Curnow P, Maresh M, Morgan M, Lewis-Barned N. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia. 2017;60(9):1668–777.
Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, Leese GP, Philip S, Lindsay RS. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia. 2018;61(5):1081–8.
Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golighty S, Miller A. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetesin England, Wales, and Northern Ireland: population based study. BMJ. 2006;333(7560):177–83.
Egan AM, Brassill MJ, Brosnan E, Carmody L, Clarke H, Coogan Kelly C, Culliney L, Durkan M, Fenlon M, Ferry P, Hanlon G. An Irish National Diabetes in pregnancy audit: aiming for best outcomes for women with diabetes. Diabet Med. 2019. https://doi.org/10.1111/dme.13923.
Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;10(1):63–77.
McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PSJ, Tsang RC. A focused pre conceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern-Fetal Med. 2000;9(1):14–20.
Confidential Enquiry into Maternal and Child Health (CEMACH) Diabetes in pregnancy: are we providing the best care? Findings of a national enquiry 2007. http://www.hqip.org.uk/assets/NCAPOP-Library/CMACE-Reports/25.-February-2007. Accessed 21 Sept 2019.
Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328(7445):915–20.
Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32(11):2005–9.
The Saint Vincent Declaration. Acta Ophthalmol Scand. 1997;75:63.
DeSilva M, Munoz FM, Mcmillan M, Kawai AT, Marshall H, Macartney KK, Joshi J, Oneko M, Rose AE, Dolk H, Trotta F. Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016;34(49):6015–26.
Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007;30(7):1920–5.
Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, Moeller M, Damm P. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32(6):1046–8.
Nielsen GL, Møller M, Sørensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care. 2006;29(12):2612–6.
Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia. 2000;43(1):79–82.
Holmes VA, Young IS, Maresh MJA, Pearson DWM, Walker JD, McCance DR, DAPIT Study Group. The diabetes and pre-eclampsia intervention trial. Int J Gynecol Obstetr. 2004;87(1):66–71.
Hummel M, Marienfeld S, Huppmann M, Knopff A, Voigt M, Bonifacio E, Ziegler AG. Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions. Diabetologia. 2007;50(4):850–8.
Cyganek K, Skupien J, Katra B, Hebda-Szydlo A, Janas I, Trznadel-Morawska I, Witek P, Kozek E, Malecki MT. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control. Endocrine. 2017;55(2):447–55.
Abell SK, Boyle JA, de Courten B, Soldatos G, Wallace EM, Zoungas S, Teede HJ. Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2017;57(3):308–14.
Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG. 2006;113(11):1329–32.
Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765–74. https://doi.org/10.1111/j.1464-5491.2008.02486.x.
Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008;51:941–51. https://doi.org/10.1007/s00124-008-0974-3.
Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I. Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service. Diabet Med. 2007;24:1419–23. https://doi.org/10.1111/j.1464-5491.2007.02287.x.
Janez A. Continuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana Slovenia, J Int Med Res. 2012;40:1546–51. https://doi.org/10.1177/147323001204000434.
Jankovec Z, Hahn M, Grunder S, Lacigova S, Cechurova D, Krcma M, Zourek M, Haladova I, Rusavy Z. Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetesu sing insulin pump therapy. Diabetes Res Clin Pract. 2010;87:219–23. https://doi.org/10.1016/j.diabres.2009.09.028.
Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JF, Sanchez JJ, Wysocki T, Ruedy K, Kollman C, Tomlinson G, Murphy HR. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care. 2018;41(12):2471–9.
Cyganek K, Skupien J, Katra B, Hebda-Szydlo A, Janas I, Trznadel-Morawska I, Witek P, Kozek E, Malecki MT. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control. Endocrine. 2017;55:447–55. https://doi.org/10.1007/s12020-016-1134-z.
Murphy HR, Elleri D, Allen JM, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55:282–93.
Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies. Eur J Endocrinol. 2018;178(5):545–63. https://doi.org/10.1530/EJE-17-0804.
National Institute for Health and Clinical Excellence. Diabetes in Pregnancy. Management of diabetes and its complications in pregnancy from the pre-conception to the postnatal period. NICE Guideline 63. 2008. www.nice.org.uk. Accessed 2015.